NIH-funded research NIH-funded research

Understanding how fat metabolism affects leukemia stem cells in children

Official title: Metabolic regulation of oxidative phosphorylation in pediatric AML relapse

Funded at Duke University · NIH-10950387 · Data updated 2026-11-12

This study is looking at how fats in our diet might help leukemia stem cells grow and survive, which could be important for understanding why acute myeloid leukemia (AML) can come back in children, and it involves testing in the lab and with animal models to see how a high-fat diet affects these cancer cells.

More Relapse research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$103,853
NIH project number1K38CA282963-01A1
Project IDNIH-10950387 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children diagnosed with acute myeloid leukemia, particularly those who have experienced relapse.

Less likely to help

Patients with other types of leukemia or those who are not currently undergoing treatment for AML may not benefit from this research.

What this research studies

This research investigates the role of lipid metabolism in supporting energy production in leukemia stem cells, which are crucial for the relapse of acute myeloid leukemia (AML) in children. By analyzing genetic data from pediatric AML patients, the study aims to uncover how fatty acids contribute to the growth and survival of these cancer cells. The researchers will conduct experiments both in the lab using leukemia cell lines and in animal models derived from pediatric patients to explore the effects of a high-fat diet on leukemia progression and energy metabolism.

Why it matters

Potential benefit: If successful, this research could lead to new treatment strategies that specifically target leukemia stem cells, potentially reducing relapse rates in pediatric AML patients.

How similar studies have gone: Previous research has shown promising results in targeting metabolic pathways in cancer, suggesting that this approach may yield significant insights and advancements.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Zachman, Derek — Duke University
  • Study coordinator: Zachman, Derek

Related research

Other NIH-funded projects on the same topics.

  • Social stress and smoking: why disadvantaged young adults struggle to quit

    This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11540695

  • Learning from remission and relapse in lupus (SLE)

    Researchers are studying people with systemic lupus erythematosus who are in long-term remission without steroids or immunosuppressants to understand their immune cells, brain function, and what might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513534

  • Learning from Remission and Relapse in SLE

    A program to study people with systemic lupus erythematosus who are in long-term remission to understand immune and brain signals that might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513533

  • Alternative NF-kB activation after chemotherapy in ovarian cancer

    This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.

    NIH research San Diego State University · San Diego, United States · NIH-11473227

  • Predictors of autoimmunity onset and relapse in skin

    A study to understand what biological signals in skin predict when autoimmune diseases start, flare, or worsen in people at risk.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11471389

  • Determinants of TB Control, Relapse, and Reinfection

    A large, multi-year study aims to understand why some people who are treated for TB still have persistent infection or relapse, with the goal of improving prevention and treatment.

    NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11449646

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.